Immune mechanisms in angiotensin II-induced target-organ damage

References

• Mai M, Geiger H, Hilgers KF, Veelken R, Mann JF, Dämmrich J, . Early interstitial changes in hypertension-induced renal injury. Hypertension. 1993;22:754–65.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrera-Acosta J, . Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol. 2002;282: F191–201.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Iturbe B, Johnson RJ. The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension. Hypertens Res. 2010;33:975–80.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Iturbe B, Franco M, Tapia E, Quiroz Y, Johnson RJ. Renal inflammation, autoimmunity and salt-sensitive hypertension. Clin Exp Pharmacol Physiol. 2012;39: 96–103.
   PubMed Web of Science ®Google Scholar
• Luft FC, Mervaala E, Müller DN, Gross V, Schmidt F, Park JK, . Hypertension-induced end-organ damage: A new transgenic approach to an old problem. Hypertension. 1999;33:212–8.
   PubMed Web of Science ®Google Scholar
• Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, . Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol. 2002;161:1679–93.
   PubMed Web of Science ®Google Scholar
• Muller DN, Mullally A, Dechend R, Park JK, Fiebeler A, Pilz B, . Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension. 2002;40:840–6.
   PubMed Web of Science ®Google Scholar
• Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, . NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 2000;35:193–201.
   PubMed Web of Science ®Google Scholar
• Henke N, Schmidt-Ullrich R, Dechend R, Park JK, Qadri F, Wellner M, . Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circ Res. 2007;101:268–76.
   PubMed Web of Science ®Google Scholar
• Shagdarsuren E, Wellner M, Braesen JH, Park JK, Fiebeler A, Henke N, . Complement activation in angiotensin II-induced organ damage. Circ Res. 2005;97:716–24.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, . Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449–60.
   PubMed Web of Science ®Google Scholar
• Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, . Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation. 2010;122:2529–37.
   PubMed Web of Science ®Google Scholar
• Gratze P, Dechend R, Stocker C, Park JK, Feldt S, Shagdarsuren E, . Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation. 2008;117:2645–56.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348–57.
   PubMed Web of Science ®Google Scholar
• Tracey KJ. Reflex control of immunity. Nat Rev Immunol. 2009:418–28.
   PubMed Web of Science ®Google Scholar
• Luft FC. Neural regulation of the immune system modulates hypertension-induced target-organ damage. J Am Soc Hypertens. 2012;6:23–6.
   PubMed Web of Science ®Google Scholar
• Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest. 2007;117:1119–27.
   PubMed Web of Science ®Google Scholar
• Yang XF, Fang P, Meng S, Jan M, Xiong X, Yin Y, . The FOX transcription factors regulate vascular pathology, diabetes and Tregs. Front Biosci. 2009;1:420–36.
   Google Scholar
• Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol. 2010;11:7–13.
   PubMed Web of Science ®Google Scholar
• Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, Schwarz I, . Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation. 2009;119:2904–12.
   PubMed Web of Science ®Google Scholar
• Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, . Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009;15:545–52.
   PubMed Web of Science ®Google Scholar
• Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, . AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000;101:2382–7.
   PubMed Web of Science ®Google Scholar
• Wenzel K, Rajakumar A, Haase H, Geusens N, Hubner N, Schulz H, . Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension. 2011;58:77–84.
   PubMed Web of Science ®Google Scholar
• Riemekasten G, Philippe A, Näther M, Slowinski T, Müller DN, Heidecke H, . Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis. 2011;70:530–6.
   PubMed Web of Science ®Google Scholar